GORDIAN PHARMA LIMITED

GORDIAN PHARMA LIMITED

  • Overview
  • Summary
  • Purpose
  • Address
  • Accounts
  • Confirmation Statement
  • Filings
  • Officers
  • Persons with significant controls
  • Data Source
  • Overview

    Company NameGORDIAN PHARMA LIMITED
    Company StatusActive
    Legal FormPrivate limited company
    Company Number 12411459
    JurisdictionWales
    Date of Creation

    Summary

    Has Super Secure PSCsNo
    Has ChargesNo
    Has Insolvency HistoryNo
    Registered Office is in DisputeNo

    What is the purpose of GORDIAN PHARMA LIMITED?

    • Research and experimental development on biotechnology (72110) / Professional, scientific and technical activities

    Where is GORDIAN PHARMA LIMITED located?

    Registered Office Address
    Aberllech
    Pentre Bach
    LD3 8UB Brecon
    Wales
    Undeliverable Registered Office AddressNo

    What are the latest accounts for GORDIAN PHARMA LIMITED?

    OverdueNo
    Next Accounts
    Next Accounts Period End OnOct 31, 2025
    Next Accounts Due OnJul 31, 2026
    Last Accounts
    Last Accounts Made Up ToOct 31, 2024

    What is the status of the latest confirmation statement for GORDIAN PHARMA LIMITED?

    Last Confirmation Statement Made Up ToJan 14, 2026
    Next Confirmation Statement DueJan 28, 2026
    Last Confirmation Statement
    Next Confirmation Statement Made Up ToJan 14, 2025
    OverdueNo

    What are the latest filings for GORDIAN PHARMA LIMITED?

    Filings
    DateDescriptionDocumentType

    Accounts for a small company made up to Oct 31, 2024

    17 pagesAA

    Statement of capital following an allotment of shares on Mar 06, 2025

    • Capital: GBP 2,091.397842
    3 pagesSH01

    Confirmation statement made on Jan 14, 2025 with updates

    7 pagesCS01

    Change of details for Morvus Technology Limited as a person with significant control on Dec 07, 2024

    2 pagesPSC05

    Statement of capital on Feb 03, 2025

    • Capital: GBP 1,856,892
    3 pagesSH19

    legacy

    1 pagesSH20

    legacy

    1 pagesCAP-SS

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    capital

    Resolution of reduction in issued share capital

    RES06

    Statement of capital following an allotment of shares on Dec 06, 2024

    • Capital: GBP 2,066.15012
    3 pagesSH01

    Memorandum and Articles of Association

    32 pagesMA

    Resolutions

    Resolutions
    1 pagesRESOLUTIONS
    Resolutions
    CategoryDateDescriptionType
    incorporation

    Resolution of adoption of Articles of Association

    RES01

    Statement of capital following an allotment of shares on Apr 30, 2024

    • Capital: GBP 1,860.035108
    3 pagesSH01

    Termination of appointment of Michael John Hudson as a director on Jul 01, 2024

    1 pagesTM01

    Accounts for a small company made up to Oct 31, 2023

    18 pagesAA

    Confirmation statement made on Jan 19, 2024 with updates

    6 pagesCS01

    Statement of capital following an allotment of shares on Sep 27, 2023

    • Capital: GBP 1,793.435108
    3 pagesSH01

    Accounts for a small company made up to Oct 31, 2022

    17 pagesAA

    Confirmation statement made on Jan 19, 2023 with no updates

    3 pagesCS01

    Accounts for a small company made up to Oct 31, 2021

    7 pagesAA

    Change of details for Morvus Technology Limited as a person with significant control on Jul 16, 2021

    2 pagesPSC05

    Confirmation statement made on Jan 19, 2022 with updates

    7 pagesCS01

    Statement of capital following an allotment of shares on Jul 16, 2021

    • Capital: GBP 1,429.4756
    3 pagesSH01

    Appointment of Mr Michael Ulic Anthony Alen-Buckley as a director on Jul 16, 2021

    2 pagesAP01

    Termination of appointment of William Philip Seymour Richards as a director on Jul 16, 2021

    1 pagesTM01

    Confirmation statement made on Jan 19, 2021 with updates

    4 pagesCS01

    Who are the officers of GORDIAN PHARMA LIMITED?

    Officers
    NameAppointed OnResigned OnRoleAddressCompany IdentificationCountry of ResidenceNationalityDate of BirthOccupationNumber
    ALEN-BUCKLEY, Michael Ulic Anthony
    La Rue De Haut
    St. Brelade
    JE3 8AR Jersey
    Beauvoir Cottage
    Jersey
    Director
    La Rue De Haut
    St. Brelade
    JE3 8AR Jersey
    Beauvoir Cottage
    Jersey
    JerseyIrishExecutive Chairman282849220001
    BEATSON-HIRD, Jonathan Denis
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    Director
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    WalesBritishDirector150163970002
    PHILLIPS, Judith Carlyon
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    Director
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    EnglandBritishChartered Secretary266237280001
    WYLLIE, Michael Grant, Dr
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    Director
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    United KingdomBritishDirector266237270002
    HUDSON, Michael John, Dr
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    Director
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    United KingdomBritishDirector105809190001
    RICHARDS, William Philip Seymour
    Adam Street
    WC2 6LE London
    1
    England
    Director
    Adam Street
    WC2 6LE London
    1
    England
    JerseyBritishDirector289368870001

    Who are the persons with significant control of GORDIAN PHARMA LIMITED?

    Persons with significant controls
    NameNotified OnAddressCeased
    Morvus Technology Limited
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    Jan 20, 2020
    Pentre Bach
    LD3 8UB Brecon
    Aberllech
    Wales
    No
    Legal FormPrivate Limited Company
    Country RegisteredUnited Kingdom
    Legal AuthorityCompanies Act 2006
    Place RegisteredCompanies House Of England And Wales
    Registration Number05115093
    Natures of Control
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the shares in the company.
    • The person holds, directly or indirectly, more than 25% but not more than 50% of the voting rights in the company.

    Data Source

    • UK Companies House
      The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
    • license: CC0